Psychomotor Disorders: Clinical Trials

405 trials for Psychomotor Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

239 completed, 50 unknown, 38 recruiting, 27 terminated. 166 Not applicable, 54 Phase 3, 54 Phase 4, 52 Phase 2, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable166Completed 93, Unknown 25, Recruiting 19, Not yet recruiting 9, Active not recruiting 8, Terminated 6, Enrolling by invitation 3, Withdrawn 2, Suspended 1
Phase 354Completed 37, Terminated 8, Recruiting 4, Active not recruiting 3, Not yet recruiting 1, Unknown 1
Phase 454Completed 37, Unknown 8, Withdrawn 5, Terminated 2, Not yet recruiting 1, Recruiting 1
Phase 252Completed 28, Terminated 9, Recruiting 5, Not yet recruiting 4, Withdrawn 3, Active not recruiting 2, Unknown 1
Phase 111Completed 7, Unknown 2, Not yet recruiting 1, Terminated 1
Early Phase 14Completed 2, Active not recruiting 1, Unknown 1

Follow Psychomotor Disorders: new trials by email Literature Review of Psychomotor Disorders trials Research Report on Psychomotor Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep
Ferrous Sulfate, Placebo - ADHD, Sleep Problems
Phase 1 / Phase 2Not yet recruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.702027-03-012026-05-04
Deep Brain Stimulation + Therapy for Stroke
Boston Scientific Vercise Deep Brain Stimulation (DBS) System, Rehabilitation Training Protocol - Stroke, Dysarthria
Not applicableNot yet recruitingPirondini, Elvira, PhD152027-01-012026-09-30
Virtual Reality to Advance Dementia Care and Quality of Life
Supervised Virtual Reality Sessions - Dementia, Agitation
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's102026-12-012026-10-26
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
SRX246, Placebo - Aggressive Behavior in Fragile X Syndome
Phase 2Not yet recruitingAzevan Pharmaceuticals802026-12-012026-10-30
Role of Omega-DEK in Childhood Apraxia of Speech
Omega-DEK, L-carnitine, Placebo - Childhood Apraxia of Speech, Verbal Apraxia
Phase 2Not yet recruitingClaudia R. Morris342026-11-012026-07-29
Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke
Stroke, Ideomotor Apraxia
RecruitingIzmir City Hospital602026-10-302026-11-03
Post-Stroke Apraxia, Motor Function, Balance, and Gait
Standardized clinical assessment - Stroke, Ideomotor Apraxia
RecruitingIzmir City Hospital542026-10-152026-11-03
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Esketamine combined with dexmedetomidine, Dexmedetomidine - Dexmedetomidine, Ketamine
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University3562026-09-282026-09-03
Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect
Dynamic Temporal and Tactile Cueing - Connect (DTTC-Connect) - Childhood Apraxia of Speech
Not applicableRecruitingNew York University682026-09-152026-09-18
Wearable Sensor Toolkit for Infant Motor Development
Motor Delay, Infant Development
Not yet recruitingShirley Ryan AbilityLab902026-09-012026-10-08
Clinical Trial of Peer Support in the ED (PCORI)
Peer-Support Enhanced Agitation Code Team (PACT) - Psychomotor Agitation, Behavioral Disorder
Not applicableNot yet recruitingYale University578702026-07-012026-05-18
Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech
Rapid Syllable Transition Treatment, Dynamic Temporal and Tactile Cueing - Childhood Apraxia of Speech, Genetic Condition
Not applicableRecruitingMurdoch Childrens Research Institute202026-07-012026-09-11
Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients
Virtual reality (VR) therapy - Delirium in the Intensive Care Unit, Sleep Quality in Adult ICU Patients
Not applicableCompletedMilton S. Hershey Medical Center202026-06-022026-10-23
Synchronous vs. Asynchronous Telerehabilitation for High-Risk Infants
Synchronous Telerehabilitation Group, Asynchronous Telerehabilitation Group - Risky Baby, Premature Birth of Newborn
Not applicableNot yet recruitingBiruni University482026-05-042026-03-30
Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
Daily Screen Exposure Duration - Agitation, Postoperative Agitation
RecruitingKanuni Sultan Suleyman Training and Research Hospital2882026-05-012026-08-05
Activation-Socialization Intervention Program for Seniors
Activation and Socialization Intervention Program - Healthy
Not applicableEnrolling by invitationDiana Ďuricová2002026-04-202026-04-09
ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
ED-TREAT - Psychomotor Agitation, Behavioral Disorder
Not applicableSuspendedYale University262026-04-012026-03-12
Rapid Syllable Transition (ReST) Interventions for Speech Sound Disorders in Children
Rapid Syllable Transition Treatment (ReST) - Childhood Apraxia of Speech
Not applicableActive not recruitingAline Mara de Oliveira202026-04-012026-06-09
Feasibility and Preliminary Effects of a Therapeutic Approach Using Ultrasound Visual Biofeedback in Children With AFI: a Pilot Randomized Clinical Trial.
Ultrasound Visual Feedback, Waitlist - Childhood Apraxia of Speech, Speech Sound Disorders
Not applicableRecruitingAline Mara de Oliveira202026-04-012026-10-27
Complex Rehabilitation Technology Enabled Physical Activity for Children With Motor Delays Via Telehealth in Natural Environments
Stander Use - Cerebral Palsy (CP), Motor Disability
Not applicableRecruitingOhio State University202026-02-192026-05-07

Showing 20 of 405. Sign in to see all of them.

Narrower conditions

Psychomotor Agitation (281)  ·  Alzheimer Disease (76)  ·  Dementia (75)  ·  Apraxias (65)  ·  Delirium (30)  ·  Schizophrenia (25)  ·  Pain (23)  ·  Stroke (22)  ·  Anxiety Disorders (21)  ·  Psychotic Disorders (21)  ·  Aggression (20)  ·  Aphasia (18)  ·  Depression (15)  ·  Emergence Delirium (14)

Broader conditions

Neurobehavioral Manifestations (405)  ·  Neurologic Manifestations (405)  ·  Pathological Conditions, Signs and Symptoms (405)  ·  Signs and Symptoms (405)  ·  Nervous System Diseases (402)  ·  Behavior (291)  ·  Dyskinesias (283)  ·  Behavioral Symptoms (279)  ·  Aberrant Motor Behavior in Dementia (278)  ·  Mental Disorders (251)  ·  Central Nervous System Diseases (160)  ·  Brain Diseases (159)  ·  Neurocognitive Disorders (159)  ·  Neurodegenerative Diseases (85)

Interventions

Dexmedetomidine (37)  ·  Haloperidol (17)  ·  Loxapine (10)  ·  Midazolam (10)  ·  Olanzapine (10)  ·  Saline Solution (10)  ·  Sodium Chloride (10)  ·  Risperidone (9)  ·  Standard of Care (8)  ·  Quetiapine Fumarate (7)  ·  Ketamine (6)  ·  ziprasidone (6)  ·  Dronabinol (5)  ·  Lorazepam (5)  ·  Music Therapy (5)

Sponsors

BioXcel Therapeutics Inc (12)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (10)  ·  Assistance Publique - Hôpitaux de Paris (6)  ·  VA Office of Research and Development (6)  ·  Axsome Therapeutics, Inc. (5)  ·  Centre for Addiction and Mental Health (5)  ·  Hennepin Healthcare Research Institute (5)  ·  Mayo Clinic (5)  ·  Alexza Pharmaceuticals, Inc. (4)  ·  Johns Hopkins University (4)  ·  Ohio State University (4)  ·  University Hospital, Angers (4)  ·  University Hospital, Clermont-Ferrand (4)  ·  Ain Shams University (3)  ·  Emory University (3)

Countries

United States (184)  ·  France (36)  ·  Canada (30)  ·  Turkey (Türkiye) (21)  ·  China (18)  ·  Spain (16)  ·  United Kingdom (15)  ·  Egypt (13)  ·  Germany (12)  ·  Italy (10)  ·  South Korea (9)  ·  Brazil (8)  ·  Norway (8)  ·  Poland (8)  ·  Australia (7)

Top investigators

BioXcel MM, MD (8)  ·  BioXcel MM (3)  ·  Julie L Wambaugh, PhD (3)  ·  Arun Jayaraman, PT, PhD (2)  ·  Aylin Dikici, MD (2)  ·  Constantine Lyketsos, MD, MHS (2)  ·  Daphne Sze Ki Cheung, PhD (2)  ·  Jacobo Mintzer, MD (2)  ·  Jennifer Felger, PhD (2)  ·  Lauren Klein, MD (2)  ·  Lon Schneider, MD (2)  ·  Nathan Herrmann, MD (2)

Results publications

PMID 40681915, PMID 41533472, PMID 41961243, PMID 39108660, PMID 41591746, PMID 23245705, PMID 23422376, PMID 24035670, PMID 29163985, PMID 31708380, PMID 34532852, PMID 35703367, PMID 36002761, PMID 40847656, PMID 41439450, PMID 41689409, PMID 42052145, PMID 42502037, PMID 10692189, PMID 11001602, PMID 11087767, PMID 11133600, PMID 11442853, PMID 11473855, PMID 11604980, PMID 12040306, PMID 15114210, PMID 15840076, PMID 16247923, PMID 16677266, PMID 16879517, PMID 17035647, PMID 17326118, PMID 17416907, PMID 17984395, PMID 18519523, PMID 18676556, PMID 19369318, PMID 19454032, PMID 19700947, PMID 19709377, PMID 19901244, PMID 20006719, PMID 20214847, PMID 20418301, PMID 20492042, PMID 20492047, PMID 20497353, PMID 20528148, PMID 20621273

NIH funding

2023 (3), 2016 (2), 2017 (2), 1RC2AG036535 (1), 1RF1AG050967-01A1 (1), 2005 (1), 2008 (1), 2009 (1), 2018 (1), 2025 (1), K23MH126366 (1), N01MH090001 (1), N01MH90001 (1), P30AG073105 (1), P50AG005136 (1)